Molecular mechanisms and therapeutic prospects of short-chain fatty acid-mediated regulation of rheumatoid arthritis via the gut-joint axis.
Rheumatoid arthritis (RA) is characterized by chronic synovial inflammation and progressive joint destruction, and approximately 30-40% of patients respond inadequately to currently available disease-modifying antirheumatic drugs. Growing evidence suggests that immune abnormalities driving joint inflammation may arise...